Shamburg News · 8-K filed Oct 20, 2026, 9:24 AM EDT
DataMeds AI Regains Compliance with Nasdaq Minimum Stockholders' Equity Rule
MEDS · DataMeds AI, Inc.
- Other event
- Reg FD disclosure
- Materiality: medium
DataMeds AI, Inc. announced on October 20, 2026 that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), the $2,500,000 minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq's Listing Qualifications Staff notified the Company by letter dated October 19, 2026. The Company had received a deficiency letter on April 13, 2026 citing stockholders' equity of $(12,447,801) reported in its 2025 Form 10-K.
Source: SEC EDGAR, Form 8-K, Items 7.01, 8.01, 9.01, accession 0001493152-26-047711.
Written from the filing by Shamburg Markets. Figures are as reported by the company.